Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis
The DOI matches its Crossref record; 94 of the 98 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We aimed to estimate pooled percentages of patients with adrenal insufficiency after treatment with corticosteroids for various conditions in a meta-analysis. Secondly, we aimed to stratify the results by route of administration, disease, treatment dose, and duration. METHODS: We searched seven electronic databases (PubMed, MEDLINE, EMBASE, COCHRANE, CENTRAL, Web of Science, and CINAHL/Academic Search Premier) in February 2014 to identify potentially relevant studies. Original articles testing adult corticosteroid users for adrenal insufficiency were eligible. RESULTS: We included 74 articles with a total of 3753 participants. Stratified by administration form, percentages of patients with adrenal insufficiency ranged from 4.2% for nasal administration (95% confidence interval [CI], 0.5-28.9) to 52.2% for intra-articular administration (95% CI, 40.5-63.6). Stratified by disease, percentages ranged from 6.8% for asthma with inhalation corticosteroids only (95% CI, 3.8-12.0) to 60.0% for hematological malignancies (95% CI, 38.0-78.6). The risk also varied according to dose from 2.4% (95% CI, 0.6-9.3) (low dose) to 21.5% (95% CI, 12.0-35.5) (high dose), and according to treatment duration from 1.4% (95% CI, 0.3-7.4) (<28 d) to 27.4% (95% CI, 17.7-39.8) (>1 year) in asthma patients. CONCLUSIONS: 1) Adrenal insufficiency after discontinuation of glucocorticoid occurs frequently; 2) there is no administration form, dosing, treatment duration, or underlying disease for which adrenal insufficiency can be excluded with certainty, although higher dose and longer use give the highest risk; 3) the threshold to test corticosteroid users for adrenal insufficiency should be low in clinical practice, especially for those patients with nonspecific symptoms after cessation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risk also varied when stratified for the underlying disease and increased with higher dose (low dose 2.4% (95% CI 0.6-9.3) to high dose 21.5% (95% CI 12.0-35.5)) and longer treatment duration (1.4% (95% CI 0.3-7.4) (<28 days) to 27.4% (95% CI 17.7-39.8) (>1 year)) in patients with asthma.”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“A meta-analysis of the risk of developing biochemical glucocorticoid-induced adrenal insufficiency stratified by glucocorticoid route of administration showed pooled percentages of 4.2% (95% CI 0.5-28.9) for nasal administration, 48.7% (95% CI 36.9-60.6) for oral use, and 52.2% (95% CI 40.5-63.6) for intra-articular administration (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“Of these 521 patients, 98 patients had biochemical evidence of adrenal insufficiency. Ten of them (10%) reported symptoms. However, 88 (90%) did not report any symptoms”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“In the above-mentioned meta-analysis, ten of the 74 included studies also assessed symptoms of adrenal insufficiency (although not systematically scored) in a total of 521 patients (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“Broersen et al performed a meta-analysis on eleven out of seventeen studies re-testing patients for biochemical adrenal insufficiency for which results could be categorized in short-term (defined as less than 4 weeks) high-dose glucocorticoid therapy re-testing after 4 weeks (six studies), and long-term (>1 year) medium-dose glucocorticoid therapy re-testing after 6 months (five studies) (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
20 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
Oelkers, W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351607 · Cited by 737
Use of oral corticosteroids in the United Kingdom
van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529
Clinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442
Schlaghecke, R., Kornely, E., Santen, R. T., & Ridderskamp, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260403 · Cited by 381
Distinguishing Case Series From Cohort Studies
Dekkers, O. M., Egger, M., Altman, D. G., & Vandenbroucke, J. P. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-1-201201030-00006 · Cited by 308
Self-citationSuppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment
Henzen, C., Suter, A., Lerch, E., Urbinelli, R., Schorno, X. H., & Briner, V. A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06290-x · Cited by 290
Greenberg, G., Feagan, B., Martin, F., Sutherland, L., Thomson, A., Williams, C., Nilsson, L., & Persson, T. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536887 · Cited by 288
Research works printed but not linked: 1
- Ruiz Munoz, 1988, Adrenocortical function and steroid doses in renal transplant patients, Dial Transplant, 17, 184
Cited by
Items 301–400 of 457
de Llano, L. P., Naval, E., Mejía, N., & Domínguez‐Ortega, J. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.2005585 · Cited by 1
Choo, Y.-H., Kim, M., Kim, J. H., Jeon, H., Jung, H.-W., Ha, E. J., Oh, J., Shim, Y., Kim, S. B., Jung, H.-G., et al. (2023) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2023.0061 · Cited by 1
Prevalence of Adrenal Insufficiency in Korean Patients undergoing Total Knee Arthroplasty
Baek, S. W., Noh, J. H., & Heo, Y. S. (2023) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.23.0123 · Cited by 1
Hao, A., Yu, R. P., Kikuchi, R., Sadrolashrafi, K., Guo, L., Yamamoto, R. K., Tolson, H. C., Yee, D. K., Bilimoria, S. N., Pourali, S. P., et al. (2024) · Dermatitis · doi:10.1089/derm.2024.0193 · Cited by 1
Iatrogenic Cushing Syndrome and Adrenal Suppression Presenting as Perimenopause
Andres, S. M., Galina, J. M., & Berga, S. L. (2024) · JCEM Case Reports · doi:10.1210/jcemcr/luae183 · Cited by 1
Treatment and Follow-up of Non-stress Adrenal Insufficiency
Buğrul, F., & Murat, N. Ö. (2024) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2024.2024-6-23-s · Cited by 5
The Mechanisms and Safety of Corticosteroid Injections in Orthopaedic Surgery
Light, J. J., John, M. P., Bonner, K. F., & Styron, J. F. (2025) · JBJS Reviews · doi:10.2106/jbjs.rvw.24.00177 · Cited by 1
Insalaco, A., Vandelli, S., Madeo, S. F., Bruzzi, P., Trevisani, V., Predieri, B., Lucaccioni, L., & Iughetti, L. (2025) · Case Reports in Pediatrics · doi:10.1155/crpe/6109378 · Cited by 1
AlMubayedh, H. O., Almehizia, R., Salam, A., Alghunaim, R., Mohammed, O., Alrbiaan, A., & Al‐Qadheeb, N. S. (2025) · Critical Care Explorations · doi:10.1097/cce.0000000000001290 · Cited by 1
“They suppress the hypothalamic-pituitary-adrenal (HPA) axis by inhibiting corticotropin-releasing hormone and adrenocorticotropic hormone, with the degree of suppression influenced by dose, duration, and potency (18–20).”
Adrenal Insufficiency in Dialysis Patients
Roueff, S., Lazareth, H., Mallart-Riancho, J., & Amar, L. (2025) · Seminars in Dialysis · doi:10.1111/sdi.70004 · Cited by 2
Insuficiencia adrenal inducida por glucocorticoides: tratamiento y seguimiento clínico
Maurell, E. R. (2025) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2025.08.008 · Cited by 1
Saiegh, L., Dakwar, B., Jovanovic, K., Rosenblat, I., Mahamed, M., & Sheikh‐Ahmad, M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1655146 · Cited by 2
Medical Management of Rhinitis
Li, S., Shaker, M. S., & Peters, A. T. (2025) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2025.09.007 · Cited by 1
Sarkar, S., Abeyagunawardena, A. S., & Sinha, R. (2025) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v14.i4.110374 · Cited by 6
Endocrine dysfunctions as complications and comorbidities of juvenile idiopathic arthritis
Kamińska, M., Spyra, A., Schröter, M., Sierpińska, A., Moczyróg, K., & Rosół, I. (2025) · Reumatologia/Rheumatology · doi:10.5114/reum/204738 · Cited by 1
Tu, M., He, H., Chen, L., Wen, Y., & Wang, H. (2025) · Toxicology Letters · doi:10.1016/j.toxlet.2025.111808 · Cited by 2
Iatrogenic Cushing’s Syndrome and the Hidden Ingredient of Artri King
Ataallah, B., & Tameemi, M. A. (2026) · Cureus · doi:10.7759/cureus.100843 · Cited by 1
“Glucocorticoid-containing medications are widely used in the management of inflammatory diseases, malignancies, and post-transplant care [7,8].”
Dreyer, A. F., Hansen, S. B., Borresen, S. W., Al-Jorani, H., Bislev, L. S., Boesen, V. B., Christensen, L. L., Glintborg, D., Jensen, R. C., Jørgensen, N. T., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-111334 · Cited by 1
Watson, S. C., Garg, P. M., & Constantacos, C. (2026) · Journal of Perinatology · doi:10.1038/s41372-026-02592-2 · Cited by 1
Wan, Y., Kong, L., & Ning, R. (2026) · Journal of Pain Research · doi:10.2147/jpr.s571167 · Cited by 1
“104 In a comparative study, 40 mg of methylprednisolone acetate (MA) and the same dose of TA were administered via intra-articular injection into the shoulder joint.”
Survey of Adrenal Insufficiency Management for Duchenne muscular dystrophy in Italy
Tornese, G., Wong, S. C., Sbrocchi, A. M., Angelis, F. D., Zito, I., Weber, D. R., & Aversa, T. (2026) · Endocrine · doi:10.1007/s12020-026-04596-6 · Cited by 1
“Chronic exposure to supraphysiologic GC doses (usually > 8–10 mg/m² hydrocortisone [HC] equivalent) for longer than 3–4 weeks suppresses the hypothalamic–pituitary– adrenal (HPA) axis, resulting in secondary or tertiary adre - nal insufficiency (AI) [ 8–13].”
Asthma and corticosteroids “odi et amo”: how to deal with it?
Borsari, L., Carbonieri, L., Verdini, L. M., Ruggieri, V., & Beghé, B. (2026) · Frontiers in Allergy · doi:10.3389/falgy.2026.1772380 · Cited by 1
Hussain, N., Brull, R., Gilron, I., Nguyen, A., D'Souza, R. S., Weaver, T., Bhatia, A., Clarke, H. A., Banik, R. K., Abdel‐Rasoul, M., et al. (2026) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-026-03118-2 · Cited by 2
Effraimidis, G., Kasotas, A., & Bargiota, Α. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag077 · Cited by 1
Gaston, L. S., Jorgensen, B., Friedman, H., Sherman, M. S., & Majzoub, J. A. (2026) · Endocrinology · doi:10.1210/endocr/bqag081
Topical and Systemic Corticosteroids
Kraft, M., Soost, S., & Worm, M. (2018) · Springer eBooks · doi:10.1007/978-3-319-40221-5_92-2 · Cited by 1
L’insuffisance surrénalienne chronique: une cause sous-estimée de fatigue chronique
Ntyonga-Pono, M.-P. (2018) · Pan African Medical Journal · doi:10.11604/pamj.2018.29.93.14583 · Cited by 1
Elnoby, A. S., & Nassar, H. S. (2021) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.1730 · Cited by 2
Neue Aspekte der Glukokortikoidsubstitution bei Nebennierenrindeninsuffizienz
Kienitz, T., & Meyer, G. (2021) · Der Internist · doi:10.1007/s00108-021-01209-4 · Cited by 3
Corticosteroid Suppression in Patients Receiving Inhaled Glucocorticoids: Time to Reassess Risk?
Martin‐Grace, J., Costello, R. W., & Sherlock, M. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac431 · Cited by 1
Physiological Effect of Glycyrrhizic Acid on Adrenal Insufficiency Induces by Glucocorticoid in Rats
Bnyean, W. A., & AL-Mousawi, Z. A. H. (2023) · Advances in Animal and Veterinary Sciences · doi:10.17582/journal.aavs/2023/11.10.1667.1672 · Cited by 1
The Role of Steroids in Performing Voice
Kwak, P. E., Crosby, T. W., & Branski, R. C. (2023) · Current Otorhinolaryngology Reports · doi:10.1007/s40136-023-00498-7 · Cited by 1
“However, it is unclear whether this biochemical adrenal suppression is clinically meaningful, and moreover, whether a taper alters this course [20].”
A case of celiac plexus block causing iatrogenic Cushing's syndrome
Chindris, A.-M., Rao, S. N., Chirilă, R. M., & Dumitrascu, A. G. (2024) · Clinical Case Reports · doi:10.1002/ccr3.8777
Tizianel, I., Ruggiero, E., Torchio, M., Simonato, M., Seresin, C., Bigolin, F., Botta, I. P., Bano, G., Storto, M. L., Scaroni, C. M., et al. (2024) · HORMONES · doi:10.1007/s42000-024-00564-9 · Cited by 2
Ortiz-Flores, A. E., Castro, M. A., Corrales, E. P., & Escobar-Morreale, H. F. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.06.011 · Cited by 1
Concomitant protothecosis and Corynespora cassiicola infection: A case report
Jiang, Z.-H., Sun, P., & Tseng, H. (2024) · Dermatologica Sinica · doi:10.4103/ds.ds-d-23-00139 · Cited by 1
Martins, L., Silvestre, S., & Monteiro, C. S. D. J. (2024) · Healthcare · doi:10.3390/healthcare12191923 · Cited by 1
Burch, M. O., da Rocha, D. G., SILVA, L. B., Silva, M. J. O. D., Assunção, R. P., Antunes, D., Mamoni, R. L., & Ponte, E. V. (2025) · Allergy and Asthma Proceedings · doi:10.2500/aap.2025.46.250041 · Cited by 1
Managing Adverse Effects Associated with Long-Term Glucocorticoid Use
Kim, M. K. (2025) · Korean Journal of Medicine · doi:10.3904/kjm.2025.100.4.158 · Cited by 1
Unintentional dexamethasone and steroid abuse among Yemeni patients: a case series
Al-Sharafi, B. A. (2025) · Journal of Clinical and Translational Endocrinology Case Reports · doi:10.1016/j.jecr.2025.100198 · Cited by 1
Luo, N., Shen, Y., Su, L., & Hao, P. (2025) · Journal of Dermatological Treatment · doi:10.1080/09546634.2025.2545297 · Cited by 1
“…investigating the incidence of aI following corticosteroid therapy, stratified by route of administration route, reported that the percentage of patients with aI ranged from 4.2% (95% CI, 0.5-28.9) for intranasal administration to 52.2% (95% CI, 40.5-63.6) for intra-articular administration (5).”
InfluentialIntranasal Corticosteroids and Adrenal Suppression: A Case Report
Kishore, S. B., & Silva, C. (2025) · Clinical Pediatrics · doi:10.1177/00099228251375270 · Cited by 1
Paparella, R., Bernabei, I., Bei, A., Fiorentini, C., Iafrate, N., Lucibello, R., Pastore, F., Pucarelli, I., & Tarani, L. (2025) · Journal of Pediatric Health Care · doi:10.1016/j.pedhc.2025.09.013 · Cited by 1
Unmasking adrenal insufficiency: the overlooked role of gastrointestinal symptoms
Savino, A., Bina, N., Muccichini, E., Segatta, F., Giammarco, V. D., Scardino, G., Paolo, D. D., Liparulo, L., & Radaelli, F. (2025) · The American Journal of Medicine · doi:10.1016/j.amjmed.2025.10.036 · Cited by 2
Crook, D. E., Sehgal, V., Kukreja, M., & Sehgal, J. (2025) · doi:10.25259/peak_16_2025 · Cited by 1
Motegi, R., Ito, S., Homma, H., Ono, N., Okada, H., Kidokoro, Y., Shiozawa, A., & Ikeda, K. (2018) · Sinusitis · doi:10.3390/sinusitis3020005 · Cited by 2
Dynamic Investigations and Diagnostic Testing
Yedinak, C. G., & Davies, K. M. (2019) · Springer eBooks · doi:10.1007/978-3-319-99817-6_15 · Cited by 3
Management of Medication Side Effects and Complications
Selby, L., & Fleming, L. (2019) · Springer eBooks · doi:10.1007/978-3-030-27431-3_9 · Cited by 1
Brunerová, L., Urbanová, J., & Brož, J. (2019) · Vnitřní lékařství · doi:10.36290/vnl.2019.052 · Cited by 1
Saito, K., Mano, C., Tatsumi, T., Ishikawa, T., Sekiguchi, M., Iwahara, Y., Hiramitsu, S., & Miyasaka, N. (2020) · Gynecological Endocrinology · doi:10.1080/09513590.2020.1743652 · Cited by 2
Louie, S. (2020) · Consultant · doi:10.25270/con.2020.09.00001 · Cited by 1
Yuen, K. C. J., Mortensen, M. J., Azadi, A., Fonkem, E., & Findling, J. W. (2021) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.246 · Cited by 1
Perspective of pharmaceutical practice in adrenal insufficiency: An integrative review
Caetano, J. D. S., de Castilho, S. R., & dos Santos, V. (2021) · Research Society and Development · doi:10.33448/rsd-v10i7.16197 · Cited by 1
Matsubayashi, S., Matsumoto, S., Senda, Y., Nakatake, N., & Hara, T. (2021) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2021.100062 · Cited by 1
A New Therapeutic Approach Based on a Reinterpretation of Asthma Control
Sogo, A., Abascal-Bolado, B., Almonacid, C., Domingo, C., Montoro, F. J., Davila, I. J., Entrenas, L. M., de Llano, L. A. P., & Carrascosa, M. I. (2023) · Barcelona Respiratory Network · doi:10.23866/brnrev:2023-m0089 · Cited by 1
Hydro-saline Alterations in Central Adrenal Insufficiency
Pivonello, R., Simeoli, C., Paola, N. D., Ferrigno, R., & Colao, A. (2023) · Endocrinology · doi:10.1007/978-3-031-27119-9_7 · Cited by 1
Letter to the Editor: Adrenocortical Insufficiency Following Glucocorticosteroid Treatment
Lindholm, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2621 · Cited by 1
Zimmerman, J. J. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.06.039 · Cited by 1
Fu, S., Liang, X., Tang, Z.-P., Kuang, Y., Qiu, C.-C., Yang, H.-Y., Huang, Z., Qin, Y., Ma, Y., & Luo, Z. (2022) · Research Square · doi:10.21203/rs.3.rs-2126989/v1 · Cited by 1
Response to the Letter by Lindholm, et al
Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2827
Self-citationAlhamza, A. H. A., Mansour, A. A., & Haddad, N. (2015) · International Archives of Medicine · doi:10.3823/1867
Forty Years Of Unrecognized Hypopituitarism Diagnosed By Physical Exam
Hudspeth, V., Fischer, W. A., & DeCherney, G. S. (2016) · AACE Clinical Case Reports · doi:10.4158/ep161426.cr
Bijnierschorsinsufficiëntie, een alledaagse zeldzaamheid
de Laar, F. A. V., van der Wiele, E., & Stikkelbroeck, N. M. M. L. (2016) · Huisarts en Wetenschap · doi:10.1007/s12445-016-0297-4 · Cited by 1
Neues zur Endokrinologe: Für die Diabetologie interessante Aspekte
Führer, D., & Scherbaum, W. A. (2017) · Der Diabetologe · doi:10.1007/s11428-017-0235-5
Statistics in Endocrinology: Meta-Analysis Advantages and Pitfalls
Dekkers, O. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65799-9
Self-citationLefèbvre, H., & Goichot, B. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.03.009
Quando e come sospettare l’insufficienza surrenalica subclinica
Mazzoli, M., & Giordano, R. (2018) · L Endocrinologo · doi:10.1007/s40619-018-0438-z
Said, Z. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
La gestione clinica dell’iposurrenalismo iatrogeno
Giordano, R. (2019) · L Endocrinologo · doi:10.1007/s40619-019-00572-7
Insufficienza surrenalica acuta nell’adulto
Pernet, J., & Ray, P. (2019) · EMC - Urgenze · doi:10.1016/s1286-9341(19)42036-x
Anterior Pituitary and Pars Intermedia Space
Romanò, N., & Shipston, M. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813814-4.00008-0 · Cited by 3
Onoda, N., Suda, T., & Kino, O. (2018) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.107.2513 · Cited by 1
La corticothérapie en rhumatologie
Mazières, B. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-74832-5.00050-6
Gonzáles, L. (2018) · Caribbean Medical Journal · doi:10.48107/cmj.2018.11.002
Ndiaye, N., Diack, N. D., Léye, Y. M., Dieng, A., Bâ, M., & Lèye, A. (2020) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2020.1012015
Sowerby, L. J., & Fowler, J. L. A. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.78206
Tonelli, F., Cotti, S., Leoni, L., Besio, R., Gioia, R., Marchese, L., Giorgetti, S., Villani, S., Gistelinck, C., Wagener, R., et al. (2021) · Yearbook of pediatric endocrinology · doi:10.1530/ey.18.5.11
Misaki, M., & Komagamine, J. (2020) · Research Square · doi:10.21203/rs.3.rs-33309/v1
Cushing’s Disease of Unknown Etiology: A Clinical Case Report
Martins, J. M., Maia, C. M., Miguéns, J., & Lopéz‐Presa, D. (2022) · Journal of Endocrinology and Metabolism · doi:10.14740/jem784
Knight, S. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-53186-3.00016-4
Adrenal insufficiency: a commentary
Ryan, A., & Twomey, P. J. (2022) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2022-208162
La supplementazione steroidea perioperatoria nel paziente iposurrenalico
Grossrubatscher, E. M., & Loli, P. (2022) · L Endocrinologo · doi:10.1007/s40619-022-01116-2
Challenges in Allergy Diagnostics and Solutions Worth Considering
Kos, S., & Sanders, R. (2018) · EMJ Allergy & Immunology · doi:10.33590/emjallergyimmunol/10310127
Insuficiencia suprarrenal secundaria persistente tras tratamiento prolongado con corticoides
Martínez, B. M., Aguirre, N. G., Fernández, L. P., & Martínez, M. M. (2021) · Revista Clínica de Medicina de Familia · doi:10.55783/rcmf.140308
Omeroglu, M., & Arslan, Ş. (2022) · Genel Tıp Dergisi · doi:10.54005/geneltip.1136552
De patiënt met koorts en algehele malaise
de Groot, B., Verdonschot, R. J. C. G., Linzel, D. S., Bouma, H. R., van Beers, E. J., & Kaasjager, K. A. H. (2023) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2805-5_30
Correa, N., & Orlando, R. A. (2023) · WikiJournal of Medicine · doi:10.15347/wjm/2023.xxx
“However, many of these drugs can only be used for short-term treatments, as their long-term use causes gastrointestinal ulcerations and thrombotic events, and in the case of corticosteroids, adrenal insufficiency.([5]) Because of this, there is an urgent need to identify alternative therapeutics for use as anti-inflam…”
BackgroundInsuffisance corticotrope postcortisonothérapie
Chafai, K., Laloi-Michelin, M., & Gautier, J. (2022) · Elsevier eBooks · doi:10.1016/b978-2-294-77859-9.00020-7
Васильевич, Б. Н. (2023) · The Clinician · doi:10.17650/1818-8338-2022-16-4-k670
Peak Flow and Mini-spirometry in the Diagnosis of Obstructive Airway Diseases
Arjun, P., Nair, S., Babu, V., Nair, A. S., Gopakumar, S., Vijayakumar, K., & Kutty, V. R. (2023) · doi:10.1177/jpm.221135948
Editorial: Adrenal insufficiency: Diagnostic approaches, treatments and outcomes
Pazderska, A., Malchoff, C. D., Ragnarsson, Ó., & Valassi, E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1180264
Sindrome di Cushing iatrogena e iposurrenalismo terziario
Alessi, Y., Cannavò, S., & Ferraù, F. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01307-5
Acute onset of mania and psychosis in the context of long-COVID: A case study
Orme, W. H., Nanavaty, N., Carlson, M. C., San Miguel, A., Jones, G. H., Head, J. H., Fowler, J. C., Podell, K., Weinstein, B. L., Blackmon, A., et al. (2023) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2023.100138
“However, secondary adrenal insufficiency from steroid withdrawal occurs in approximately 1% of patients taking steroids for less than 28 days (Broersen et al., 2015) and localized skin discoloration is typically a manifestation of primary adrenal insufficiency (Pelewicz and Miśkiewicz, 2021).”
Insufficienza surrenalica da sospensione di glucocorticoidi esogeni
Vincenzi, L., Sbardella, E., & Isidori, A. M. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01319-1
Srinivasagopalane, B., Somasundaram, K., & Balasubramaniyan, T. (2023) · World Journal of Endocrine Surgery · doi:10.5005/jp-journals-10002-1448
Hydro-saline Alterations in Central Adrenal Insufficiency
Pivonello, R., Simeoli, C., Paola, N. D., Ferrigno, R., & Colao, A. (2022) · Endocrinology · doi:10.1007/978-3-030-44628-4_7-1
Studen, K. B., Gaberšček, S., Pirnat, E., Bajuk, N. B., Vendramin, A., Majcen, V., & Zaletel, K. (2023) · Endocrine Connections · doi:10.1530/ec-23-0054
Kotwal, N., Bansal, N., Muthukrishnan, J., & Verma, V. (2023) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2023.08.017
Oral Glucocorticoid withdrawal and assessment of the hypothalamic-pituitary-adrenal axis
Correia, S., da Silva, J. I. B. S., Rocha, G., & Oliveira, M. (2023) · Revista Portuguesa de Endocrinologia Diabetes e Metabolismo · doi:10.26497/ar220048
Metadata
- Authors
- Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M.
- Affiliations
- Leiden University Medical Center (NL)
- Aarhus University (DK)
- Corresponding author
- Dekkers, Olaf M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-06-01
- Volume
- 100
- Issue
- 6
- Pages
- 2171-2180
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2022140603
- Cited by
- 456
- References
- 98
- Citations by year
- 2026: 39 · 2025: 53 · 2024: 50 · 2023: 55 · 2022: 52 · 2021: 48 · 2020: 53 · 2019: 39 · 2018: 28 · 2017: 20 · 2016: 14 · 2015: 5
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- Novo Nordisk Fonden (NNF-13OC0007869)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- adrenal insufficiency, glucocorticoid-induced adrenal insufficiency, corticosteroid use, glucocorticoid dose, treatment duration, route of administration, intra-articular corticosteroids, inhaled corticosteroids, asthma, hematologic malignancies, adrenal function testing
- MeSH terms
- Adrenal Cortex Hormones, Adrenal Insufficiency, Adult, Dosage Forms, Dose-Response Relationship, Drug, Drug Administration Routes, Drug Administration Schedule, Humans, Inflammation, Neoplasms, Skin Diseases, Organ Transplantation, Transplantation Conditioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.